A class of derivatives of malonic acid monoester acylated amino acid (+) 2-alcohol esters and their applications

A technology for the acylation of malonate monoester and amino acids, which is applied to the active ingredients of heterocyclic compounds, medical preparations containing active ingredients, and drug combinations, etc., and can solve problems such as failure to obtain effects, respiratory failure, and poor drug efficacy , to achieve the effect of reducing ischemic injury and excellent neuroprotective effect

Active Publication Date: 2021-11-05
NANJING MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

(+) The side effects of 2-alcohol are mainly allergic reactions. The use of large doses of borneol can stimulate the gastrointestinal tract, leading to nausea, vomiting, abdominal pain and diarrhea, and the central nervous system will also be overexcited, eventually leading to convulsions, loss of consciousness, and convulsions , severe cases may lead to respiratory failure and death
[0006] The applicant found that both ZLc-002 and (+) 2-canol showed good in vitro neuroprotective effects at lower concentrations, but with higher concentrations, no better effect could be obtained, or even worse efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A class of derivatives of malonic acid monoester acylated amino acid (+) 2-alcohol esters and their applications
  • A class of derivatives of malonic acid monoester acylated amino acid (+) 2-alcohol esters and their applications
  • A class of derivatives of malonic acid monoester acylated amino acid (+) 2-alcohol esters and their applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] The following examples can be understood by those skilled in the art, but the present invention is not intended in any way. Example 1: Synthesis of Target Compound:

[0015] 1.1 Synthesis of Target Compound 1:

[0016] synthetic route:

[0017]

[0018] Operation: Boc-D-VAL (1.54 g, 10 mmol), (+) 2-崁 alcohol (3.26 g, 15 mmol) was added to 100 mL of the solution, and 50 ml of dichloromethane is dissolved, and then add EDCI to the solution. (3.6 g 20 mmol), and DMAP (2 mmol), the mixture was stirred at room temperature for about 6 h, TLC monitored the reaction process, which was developed with phosphomolybdic acid. Spun decompression, rapid column chromatography obtained 3.2 g of colorless oil (mobile phase: petroleum ether: ethyl acetate, volume ratio = 20: 1). Dissolved with 10 ml of ethyl acetate, a dry HCl gas was introduced, and the TLC was monitored after 15 min, and a large amount of white solid was halved under reduced pressure, slurry with diethyl ether and filtere...

Embodiment 2

[0037] Example 2: Target compounds on neuroprotective effects

[0038] 2.1 Cultivation of primary neurons

[0039] ICR mice with agents of 15 to 16 days were taken, and after the cervical spine was dislocated, the uterus was separated from the placenta, and the removed fetal rats were placed in a 0.1% new neutral solution, and 75% sterilized. The left hand fixed counter, the right hand is separated by the eye, revealing the brain hemisphere, cauting with the eyes of the two sides of the cerebral cortex, placed in a platter with 10 ml D-HANKS. After all were taken, the mening film was released in another 1 plate with 10 ml D-HANKS, and then 5 ml D-HANKS washed once. The cortex was cut into the plate with a 37 ° C incubator (2 ml 0.25% pancreatic enzyme + 2 ml D-Hanks), and transferred to the small beaker, mixed into the small beaker. Digestion in the box for 10 min. After taking out from the incubator, 5 ml of DMEM + 10% FBS was added to terminate digestion, and after mixing, trans...

Embodiment 3

[0047] Example 3: Protective effect of target compound on focal cerebral ischemia-reperfusion

[0048] 3.1 Preparation of focal cerebral ischemia reperfusion model

[0049] After 2% hydrated chloroform (0.2 ml / 10g, IP) anesthesia, the animal is fixed to the operating table, cutting the skin along the neck, bluntly separating the neck muscle tissue, exposes the right neck pressure ( CCA) and be careful; gently peel the accompanying vagus nerve, ligation and cut the neck of the neck (ECA) of the inner and superficial walking (ECA); in the nearby sides Branch artery - pterygium artery, separating it. The CCA is close to the center of surgery; the distal end of the knotted line is scratched by the eye, and the surgery uses the nylon line (8 / 0) from the mouse to the blender, inserted, inserted along the small mouth. 16-17mm (mouse) feels slight resistance, and the front end of the line has reached the anterior artery. At this point, the blood supply of the brain medium artery (MCA) i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A derivative of amino acid (+) 2-alcohol ester of malonate monoester acylation and application thereof, the structure conforms to general formula (I): wherein: R 1 is an alkyl group of 3-4 carbon atoms, R 2 It is -H, an alkyl group of 1-6 carbon atoms, and 4-methylpiperazine. The compound has excellent neuroprotective effect, can reduce ischemic injury, and can be used for preparing medicines for treating diseases such as cerebral apoplexy.

Description

Technical field [0001] The present invention is a pharmaceutical field, and more particularly to derivatives of amino acid (+) 2-glycol ester of a class of malonic acid monoester. Background technique [0002] Cerebral infarction (ischemic stroke) has high mortality, high residual rate, high recurrence rate, and serious harm to human health. Because the brain tissue structure is fine, it is particularly sensitive to ischemic hypoxia damage, so far, it has less pretty therapeutic drugs. [0003] Under cerebral ischemia, excitatory amino acids (such as glutamic acid) are over-released, causing excessive activation of N-methyl-D-Tianmenpine receptors (NMDAR), pathological pathology through NMDAR-PSD-95-NNOS The nitric oxide (NO) was released. NNOS PDZ inhibitor N- (2-methoxycarbonyl acetyl) -D-proline methyl ester (ZLC-002, Nature Medicine 201420 (9): 1050-1054) shows a clear neuroprotection in the cell model Journal of Nanjing Medical University 2014, 314-322). Unfortunately, the a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07C233/47C07D211/46A61P9/10A61K31/445A61K31/223
CPCA61P9/10C07C233/47C07D211/46C07C2601/08C07C2601/14C07C2602/42
Inventor 李飞杨磊周宇陈轩陈冬寅蒋南罗春霞厉廷有秦亚娟王秀珍张宏娟
Owner NANJING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products